Trial Profile
Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2020
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 03 Dec 2020 Status changed from recruiting to discontinued.
- 14 Jun 2013 New trial record